BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30618185)

  • 1. Downregulation of HDAC2 and HDAC3 via oleuropein as a potent prevention and therapeutic agent in MCF-7 breast cancer cells.
    Bayat S; Mansoori Derakhshan S; Mansoori Derakhshan N; Shekari Khaniani M; Alivand MR
    J Cell Biochem; 2019 Jun; 120(6):9172-9180. PubMed ID: 30618185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hopeful anticancer role of oleuropein in breast cancer through histone deacetylase modulation.
    Mansouri N; Alivand MR; Bayat S; Khaniani MS; Derakhshan SM
    J Cell Biochem; 2019 Oct; 120(10):17042-17049. PubMed ID: 31119806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous downregulation of miR-21 and miR-155 through oleuropein for breast cancer prevention and therapy.
    Abtin M; Alivand MR; Khaniani MS; Bastami M; Zaeifizadeh M; Derakhshan SM
    J Cell Biochem; 2018 Sep; 119(9):7151-7165. PubMed ID: 29905007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression.
    Müller BM; Jana L; Kasajima A; Lehmann A; Prinzler J; Budczies J; Winzer KJ; Dietel M; Weichert W; Denkert C
    BMC Cancer; 2013 Apr; 13():215. PubMed ID: 23627572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosmarinic Acid, a Component of Rosemary Tea, Induced the Cell Cycle Arrest and Apoptosis through Modulation of HDAC2 Expression in Prostate Cancer Cell Lines.
    Jang YG; Hwang KA; Choi KC
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation.
    Paul B; Li Y; Tollefsbol TO
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
    Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
    Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
    Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
    Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome analysis of genes associated with breast cancer cell motility in response to Artemisinin treatment.
    Kumari K; Keshari S; Sengupta D; Sabat SC; Mishra SK
    BMC Cancer; 2017 Dec; 17(1):858. PubMed ID: 29246124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oleuropein inhibits migration ability through suppression of epithelial-mesenchymal transition and synergistically enhances doxorubicin-mediated apoptosis in MCF-7 cells.
    Choupani J; Alivand MR; M Derakhshan S; Zaeifizadeh M; S Khaniani M
    J Cell Physiol; 2019 Jun; 234(6):9093-9104. PubMed ID: 30317622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTP1B phosphatase as a novel target of oleuropein activity in MCF-7 breast cancer model.
    Przychodzen P; Kuban-Jankowska A; Wyszkowska R; Barone G; Bosco GL; Celso FL; Kamm A; Daca A; Kostrzewa T; Gorska-Ponikowska M
    Toxicol In Vitro; 2019 Dec; 61():104624. PubMed ID: 31419504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oleuropein, the Main Polyphenol of
    Ruzzolini J; Peppicelli S; Andreucci E; Bianchini F; Scardigli A; Romani A; la Marca G; Nediani C; Calorini L
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30544808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleuropein induces apoptosis via abrogating NF-κB activation cascade in estrogen receptor-negative breast cancer cells.
    Liu L; Ahn KS; Shanmugam MK; Wang H; Shen H; Arfuso F; Chinnathambi A; Alharbi SA; Chang Y; Sethi G; Tang FR
    J Cell Biochem; 2019 Mar; 120(3):4504-4513. PubMed ID: 30260018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-31 shuttled by halofuginone-induced exosomes suppresses MFC-7 cell proliferation by modulating the HDAC2/cell cycle signaling axis.
    Xia X; Wang X; Zhang S; Zheng Y; Wang L; Xu Y; Hang B; Sun Y; Lei L; Bai Y; Hu J
    J Cell Physiol; 2019 Aug; 234(10):18970-18984. PubMed ID: 30916359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating Survivin.
    Zhang L; Wang G; Wang L; Song C; Leng Y; Wang X; Kang J
    Mol Cell Biochem; 2012 Feb; 361(1-2):39-45. PubMed ID: 21959976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Histone Deacetylase Inhibition on the Expression of Multidrug Resistance-associated Protein 2 in a Human Placental Trophoblast Cell Line.
    Duan HY; Ma D; Zhou KY; Wang T; Zhang Y; Li YF; Wu JL; Hua YM; Wang C
    Chin Med J (Engl); 2017 Jun; 130(11):1352-1360. PubMed ID: 28524836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol up-regulates ATP2A3 gene expression in breast cancer cell lines through epigenetic mechanisms.
    Izquierdo-Torres E; Hernández-Oliveras A; Meneses-Morales I; Rodríguez G; Fuentes-García G; Zarain-Herzberg Á
    Int J Biochem Cell Biol; 2019 Aug; 113():37-47. PubMed ID: 31173924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis and Biological Evaluation of Novel N-hydroxyheptanamides Incorporating 6-hydroxy-2-methylquinazolin-4(3H)-ones as Histone Deacetylase Inhibitors and Cytotoxic Agents.
    Minh NV; Thanh NT; Lien HT; Anh DTP; Cuong HD; Nam NH; Hai PT; Minh-Ngoc L; Le-Thi-Thu H; Chinh LV; Vu TK
    Anticancer Agents Med Chem; 2019; 19(12):1543-1557. PubMed ID: 31267876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of anticancer mechanism of oleuropein via cell cycle and apoptotic pathways in SH-SY5Y neuroblastoma cells.
    Seçme M; Eroğlu C; Dodurga Y; Bağcı G
    Gene; 2016 Jul; 585(1):93-99. PubMed ID: 27032461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting breast cancer stem cells by novel HDAC3-selective inhibitors.
    Hsieh HY; Chuang HC; Shen FH; Detroja K; Hsin LW; Chen CS
    Eur J Med Chem; 2017 Nov; 140():42-51. PubMed ID: 28923385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.